Catalyst Wire Dossier Catalyst Wire Dossier

IVIG/Rituximab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IVIG/Rituximab, covering 2022-10-26 to 2022-10-26. Get the full timeline:

Most recent: Clinical Trial Update: IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies [Phase 4]

See pricing